CVS Health Q4 Adjusted EPS $2.12 Beats $1.99 Estimate, Sales $93.81B Beat $90.36B Estimate
Portfolio Pulse from Benzinga Newsdesk
CVS Health reported Q4 adjusted EPS of $2.12, surpassing the $1.99 estimate, and sales of $93.81B, exceeding the $90.36B estimate. This represents a 3.92% increase in earnings and an 11.89% increase in sales from the same period last year.
February 07, 2024 | 11:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CVS Health exceeded Q4 earnings and sales estimates, showing a 3.92% increase in EPS and an 11.89% increase in sales year-over-year.
CVS Health's Q4 earnings and sales not only surpassed analyst expectations but also showed significant growth compared to the same period last year. This positive performance is likely to instill investor confidence and could lead to a short-term uptick in CVS's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100